PTCT Insider Trading Activity and SEC Form 4 Filings
Trump's trades in PTCT
From his financial disclosures
$95K+
4 purchases
$115K+
3 sales
Sale
Jul 29, 2026
Reported 55d later
$15K - $50K
Purchase
Jun 22, 2026
Reported 61d later
$15K - $50K
Purchase
Jun 4, 2026
Reported 79d later
$15K - $50K
Sale
Apr 30, 2026
Reported 62d later
$50K - $100K
Purchase
Mar 4, 2026
Reported 71d later
$15K - $50K
Purchase
Feb 26, 2026
Reported 77d later
$50K - $100K
Many orders in these accounts are placed by the account manager. See all 7 trades
PTCT insider trading summary
Over the past 12 months, insiders at Ptc Therapeutics, Inc. (PTCT) reported 193 sales worth $53.4M by 13 insiders and no open-market purchases on SEC Form 4. Net insider selling was $53.4M.
Latest PTCT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 14, 2026 | Michael Schmertzler | Insider | Sell | $23K (382 @ $60.14) |
| Oct 14, 2026 | Michael Schmertzler | Insider | Sell | $126K (2,118 @ $59.52) |
| Oct 9, 2026 | Mark Elliott Boulding | Exec. VP and CLO | Sell | $12K (192 @ $64.26) |
| Oct 7, 2026 | Michael Schmertzler | Insider | Sell | $155K (2,447 @ $63.38) |
| Oct 7, 2026 | Michael Schmertzler | Insider | Sell | $3K (53 @ $63.95) |
| Oct 6, 2026 | Mark Elliott Boulding | Exec. VP and CLO | Sell | $28K (435 @ $64.16) |
| Oct 5, 2026 | Mark Elliott Boulding | Exec. VP and CLO | Sell | $105K (1,638 @ $64.03) |
| Sep 30, 2026 | Glenn Jr Md Phd Steele | Insider | Sell | $782K (12,000 @ $65.16) |
| Sep 17, 2026 | Michael Schmertzler | Insider | Sell | $26K (376 @ $68.45) |
| Sep 17, 2026 | Michael Schmertzler | Insider | Sell | $653K (9,624 @ $67.83) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.